Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Chromatin Accessibility Analysis from Fresh and Cryopreserved Human Ovarian Follicles.
Journal: Molecular human reproduction
Published: December 09, 2021
Specialist physicians' referral behavior regarding preimplantation genetic testing for single-gene disorders: Is there room to grow?
Journal: F&S reports
Published: November 05, 2020
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
Journal: Obstetrics and gynecology
Published: May 28, 2020
Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.
Journal: American journal of obstetrics and gynecology
Published: March 20, 2020
Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.
Journal: The New England journal of medicine
Published: January 24, 2020
Reprint of: Histological dating of timed endometrial biopsy tissue is not related to fertility status.
Journal: Fertility and sterility
Published: October 19, 2019
Controlled Ovarian Stimulation Protocols Alter Endometrial Histomorphology and Gene Expression Profiles.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: May 08, 2019
A 12-month extension study to evaluate the safety and efficacy of asoprisnil in women with heavy menstrual bleeding and uterine fibroids.
Journal: Human reproduction open
Published: January 25, 2019
Effect of single-dose ibuprofen on follicular fluid levels of interleukins in poor responders undergoing in vitro fertilization.
Journal: Systems biology in reproductive medicine
Published: December 21, 2018
Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
Journal: Obstetrics and gynecology
Published: October 11, 2018
Last Updated: 09/26/2026